You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 6, June 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Evidence-Based Dermatology: Research Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Viral Infections
 •Evidence-Based Medicine
 •Randomized Controlled Trial
 •Dermatologic Disorders, Other
 •Alert me on articles by topic

At What Rates Do Commonly Used Local Treatments Lead to Complete Disappearance of the Treated Wart?

Michael Bigby, MD

Arch Dermatol. 2003;139:801-802.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Commentary on: Local treatments for cutaneous warts: systematic review
Gibbs S, Harvey I, Sterling J, Stark R
BMJ. 2002;325:461

Question: In immunocompetent children and adults, at what rate do commonly used local treatments lead to complete disappearance of the treated wart?

Objective: To assess the evidence for the efficacy of local treatments for cutaneous warts.

Methods: Systematic review of randomized controlled trials.

Main Outcome Measures: Total clearance of warts and adverse effects such as irritation, pain, and blistering.

Study Selection: Randomized controlled trials of any local treatment for uncomplicated cutaneous warts. All published and unpublished material was considered, with no restriction on date or language.

Results: Fifty trials provided generally weak evidence because of poor methods and reporting. The best evidence was for topical treatments containing salicylic acid. Data pooled from 6 placebo-controlled trials showed a cure rate of 75% (144 of 191) in cases compared with . . . [Full Text of this Article]

Comment

Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Mass



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Documented Responses From Patients Regarding Warts and Current Therapy
Arch Dermatol 2004;140:487-488.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.